# Magnetocardiography Endocrine Registry

> **NCT04739254** · — · SUSPENDED · sponsor: **Genetesis Inc.** · enrollment: 250 (estimated)

## Conditions studied

- Endocrine Disorder

## Interventions

- **DIAGNOSTIC_TEST:** CardioFlux

## Key facts

- **NCT ID:** NCT04739254
- **Lead sponsor:** Genetesis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-12-14
- **Primary completion:** 2022-05-01
- **Final completion:** 2030-05-01
- **Target enrollment:** 250 (ESTIMATED)
- **Why stopped:** Resourcing
- **Last updated:** 2023-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04739254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04739254, "Magnetocardiography Endocrine Registry". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04739254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*